ICBI, Inc.

ICBII is a development-stage biotechnology company. Its biologics specifically target pathologic pro

ICBII has developed the breakthrough SMART Molecule Technology Platform (SM), capable of delivering therapeutic drugs across the blood-brain barrier (BBB) into the central nervous system (CNS) to diagnose and alter the course of brain diseases.